A detailed history of Tucker Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Tucker Asset Management LLC holds 793 shares of AMGN stock, worth $209,740. This represents 0.05% of its overall portfolio holdings.

Number of Shares
793
Previous 1,797 55.87%
Holding current value
$209,740
Previous $511 Million 51.5%
% of portfolio
0.05%
Previous 0.12%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$262.75 - $319.31 $263,801 - $320,587
-1,004 Reduced 55.87%
793 $248 Million
Q1 2024

Aug 09, 2024

BUY
$268.87 - $324.56 $275,054 - $332,024
1,023 Added 132.17%
1,797 $511 Million
Q4 2023

Mar 04, 2024

BUY
$255.7 - $288.46 $26,848 - $30,288
105 Added 15.7%
774 $223 Million
Q3 2023

Dec 04, 2023

BUY
$218.65 - $271.46 $19,241 - $23,888
88 Added 15.15%
669 $180 Million
Q2 2023

Sep 08, 2023

SELL
$214.27 - $253.37 $9,642 - $11,401
-45 Reduced 7.19%
581 $129 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $64,124 - $78,156
284 Added 83.04%
626 $151 Million
Q4 2022

May 11, 2023

BUY
$229.03 - $291.01 $22,903 - $29,101
100 Added 23.87%
519 $137 Million
Q3 2022

May 11, 2023

BUY
$224.46 - $253.15 $23,343 - $26,327
104 Added 33.02%
419 $113 Million
Q2 2022

May 11, 2023

SELL
$230.71 - $256.74 $10,612 - $11,810
-46 Reduced 12.74%
315 $76.6 Million
Q1 2022

May 11, 2023

BUY
$219.27 - $242.57 $74,990 - $82,958
342 New
342 $82.7 Million
Q4 2021

May 11, 2023

SELL
$198.88 - $227.6 $52,703 - $60,314
-265 Reduced 42.33%
361 $81.8 Million
Q3 2021

Aug 10, 2023

BUY
$212.27 - $248.7 $19,104 - $22,383
90 Added 47.87%
278 $57.5 Million
Q2 2021

Aug 10, 2023

BUY
$233.58 - $259.14 $6,540 - $7,255
28 Added 17.5%
188 $45.8 Million
Q1 2021

Aug 10, 2023

SELL
$221.91 - $258.6 $103,410 - $120,507
-466 Reduced 74.44%
160 $39.8 Million
Q4 2020

Jun 07, 2023

SELL
$216.38 - $257.67 $116,845 - $139,141
-540 Reduced 86.26%
86 $19.8 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Tucker Asset Management LLC Portfolio

Follow Tucker Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tucker Asset Management LLC with notifications on news.